[1] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[2] |
CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili.
One case of severe liver injury caused by Tianma Shouwu tablets
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
|
[3] |
ZUO Tiantian, WANG Zhao, GUO Yuansheng, WEI Feng, JIN Hongyu, MA Shuangcheng.
Non-carcinogenic and carcinogenic risk assessment of toxic elements in Panax quinquefolium L. based on multi-element semi-quantitative screening
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1108-1112.
|
[4] |
CAO Lin, RAN Zheng, HOU Qiang, QIU Zuocheng, YANG Jianhua.
Chemical composition of Huatie compound and prediction of potential mechanism for prevention and treatment of hyperplasia of mammary glands
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1113-1120.
|
[5] |
HUANG Jinjian, ZHANG Xiaomeng, ZHANG Bing, DING Xueli, YANG Ying, LIN Zhijian.
Cardiovascular risk signaling mining and mechanism of uric acid-lowering drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 866-871.
|
[6] |
ZOU Dongmei, FANG Fang, GUO Yixian, NI Jing, ZHAO Hong, HU Ronghua, SUN Wanling.
Analysis of the association of adverse reactions with relative dose of melphalan and body weight in POEMS syndrome patients undergoing melphalan-based ASCT
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 911-914.
|
[7] |
ZUO Zeping, TIAN Yingying, XU Yi, JIANG Kewu, YANG Shuo, YANG Hairun, ZHANG Zhicong, CAO Xinyao, WU Xiaoru, WANG Zhibin.
Preclinical safety evaluation of Jinkui Shenqi pills
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 775-782.
|
[8] |
YU Lecheng, HAO Kunyan, FAN Ye.
Clinical diagnosis of Chinese-herbal-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 481-488.
|
[9] |
DING Zihe, ZHANG Yanqiong, LIN Na.
Component-effect/toxicity-target correlations of Tripterygium wilfordii in terms of lipid metabolism
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 489-495.
|
[10] |
LUO Qiong, LI Meng, LI Guangyao, HE Yanchun, ZHOU Zushan, SUN Xin, LIU Chenghai.
Chinese medical evidence and characteristics of combined medication in 635 cases of rheumatoid arthritis patients with liver injury caused by the application of Tripterygium wilfordii preparations
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 500-504.
|
[11] |
CAO Lin, JU Bowei, RAN Zheng, YANG Jianhua, HU Junping.
Protective effects of phenylethanol glycosides of herba cistanche on mice with cholestatic liver disease
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 286-291.
|
[12] |
LI Meng, LI Rongrong, LIU Chenghai.
Clinic diagnosis and treatment of herb-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 127-131.
|
[13] |
YU Jie, ZHU Haoxiang, ZHANG Jiming.
A case of suspected drug induced liver injury caused by Senecio Scandens
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 136-139.
|
[14] |
ZHAI Yuxia, ZHANG Xiaoying, MEN Weijie, CHENG Liyuan, ZHANG Yue, ZHOU Kun.
Interactions of Psoralea corylifolia L. with Astragali Radix and Paeoniae Radix Rubra in rats based on pharmacokinetics
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 152-156.
|
[15] |
HU Jingnan, FENG Yu, TIAN Yilong, WANG Xinguo, NIU Liying.
Research progress in chemical constituents and pharmacological effects of phytoecdysterone from Cyanotis arachnoidea
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 231-235.
|